This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hognlei Zhang: Innovator in Pharmaceutical Compounds
Introduction
Hognlei Zhang is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compounds. His work focuses on enhancing the delivery of therapeutic agents, which is crucial for effective medical treatments.
Latest Patents
Hognlei Zhang holds a patent for a cationic lipid compound, which is detailed in his patent titled "Cationic lipid compound, composition containing same and use thereof." This patent describes a compound of formula (I), or an N-oxide, solvate, pharmaceutically acceptable salt, or stereoisomer thereof. The patent also outlines a composition containing the aforementioned compound and its use in the delivery of therapeutic or prophylactic agents. He has 1 patent to his name.
Career Highlights
Hognlei Zhang is associated with Hangzhou Tianlong Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work at the company has positioned him as a key player in the development of new medical solutions.
Collaborations
Hognlei Zhang collaborates with notable colleagues, including Gengshen Song and Huanyu Wang. Their combined efforts contribute to advancing research and development in the pharmaceutical sector.
Conclusion
Hognlei Zhang's innovative work in pharmaceutical compounds showcases his commitment to improving medical treatments. His contributions are vital for the ongoing advancement of therapeutic delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile